Your browser doesn't support javascript.
loading
Mechanism for antigenic peptide selection by endoplasmic reticulum aminopeptidase 1.
Giastas, Petros; Mpakali, Anastasia; Papakyriakou, Athanasios; Lelis, Aggelos; Kokkala, Paraskevi; Neu, Margarete; Rowland, Paul; Liddle, John; Georgiadis, Dimitris; Stratikos, Efstratios.
Afiliación
  • Giastas P; Institute of Nuclear & Radiological Sciences and Technology, Energy & Safety, National Centre for Scientific Research Demokritos, Agia Paraskevi, Athens 15341, Greece.
  • Mpakali A; Institute of Nuclear & Radiological Sciences and Technology, Energy & Safety, National Centre for Scientific Research Demokritos, Agia Paraskevi, Athens 15341, Greece.
  • Papakyriakou A; Institute of Biosciences & Applications, National Centre for Scientific Research Demokritos, Agia Paraskevi, Athens 15341, Greece.
  • Lelis A; Institute of Biosciences & Applications, National Centre for Scientific Research Demokritos, Agia Paraskevi, Athens 15341, Greece.
  • Kokkala P; Laboratory of Organic Chemistry, Chemistry Department, University of Athens, Athens 15771, Greece.
  • Neu M; Laboratory of Organic Chemistry, Chemistry Department, University of Athens, Athens 15771, Greece.
  • Rowland P; Medicinal Science and Technology, GlaxoSmithKline, Hertfordshire SG1 2NY, United Kingdom.
  • Liddle J; Medicinal Science and Technology, GlaxoSmithKline, Hertfordshire SG1 2NY, United Kingdom.
  • Georgiadis D; Medicinal Science and Technology, GlaxoSmithKline, Hertfordshire SG1 2NY, United Kingdom.
  • Stratikos E; Laboratory of Organic Chemistry, Chemistry Department, University of Athens, Athens 15771, Greece.
Proc Natl Acad Sci U S A ; 116(52): 26709-26716, 2019 Dec 26.
Article en En | MEDLINE | ID: mdl-31843903
ABSTRACT
Endoplasmic reticulum aminopeptidase 1 (ERAP1) is an intracellular enzyme that optimizes the peptide cargo of major histocompatibility class I (MHC-I) molecules and regulates adaptive immunity. It has unusual substrate selectivity for length and sequence, resulting in poorly understood effects on the cellular immunopeptidome. To understand substrate selection by ERAP1, we solved 2 crystal structures of the enzyme with bound transition-state pseudopeptide analogs at 1.68 Å and 1.72 Å. Both peptides have their N terminus bound at the active site and extend away along a large internal cavity, interacting with shallow pockets that can influence selectivity. The longer peptide is disordered through the central region of the cavity and has its C terminus bound in an allosteric pocket of domain IV that features a carboxypeptidase-like structural motif. These structures, along with enzymatic and computational analyses, explain how ERAP1 can select peptides based on length while retaining the broad sequence-specificity necessary for its biological function.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2019 Tipo del documento: Article País de afiliación: Grecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2019 Tipo del documento: Article País de afiliación: Grecia
...